Research highlights the gut microbiome's critical role in regulating immune response, particularly in sepsis. Antibiotics negatively impact diversity, increasing sepsis risk. While findings in mice are promising, human trials are needed.
Intermittent energy restriction (IER) changes the gut-brain-microbiome axis, influencing brain activity linked to hunger and food habits. This leads to weight loss and significant metabolic improvements in overweight adults, highlighting a complex biological interaction.
ASU study reveals gut microbes producing methane impact calorie absorption from fiber-rich foods. Higher methane equals more calorie extraction, impacting personalized nutrition.
Study explores tongue coating composition for Parkinson's disease detection. Palmitoylethanolamide shows potential as a biomarker. Non-invasive tongue sampling offers a cost-effective diagnostic tool.
GlycoCaging delivers anti-inflammatory drugs directly to the gut, reducing dosages up to 10x compared to current IBD treatments and minimizing side effects. This targeted approach shows promise for gut infections.
